Nano24

📍 Tel Aviv, Israel🗓 Founded 2020👥 5 employees💰 Last funded Sep 2019
Biotechnology Research🌐 nano24med.com
Website LinkedIn
The new revolution in immunomodulators: Efficient & safer than steroids. Clinical stage company developing IP protected CD24 enriched exosome as a therapy for pulmonary & systemic diseases involving cytokine storm, the death junction for millions of lives per year. Our technology is based on decades of research into the biology of CD24 in the laboratory of Prof. Nadir Arber and Dr. Shiran Shapira at the Tel Aviv Sourasky Medical Centre. We imagined a world where every problem has a simple innovative solution. We now build that world.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Nano24?
Nano24 has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Nano24 last raise funding?
The most recent investment in Nano24 recorded on gritt.io was in September 2019.
When was Nano24 founded?
Nano24 was founded in 2020.
What industry is Nano24 in?
Nano24 operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nano24 based?
Nano24 is headquartered in Tel Aviv, Israel.